Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report - 17/08/11

Doi : 10.1016/j.jaci.2006.03.045

Cezmi A. Akdis, MD ^a, Mübeccel Akdis, MD, PhD ^a, Thomas Bieber, MD, PhD ^b, Carsten Bindslev-Jensen, MD ^c, Mark Boguniewicz, MD ^d,^e, Philippe Eigenmann, MD ^f, Qutayba Hamid, MD, PhD ^g, Alexander Kapp, MD, PhD ^h, Donald Y.M. Leung, MD, PhD ^d, Jasna Lipozencic, MD, PhD ⁱ, Thomas A. Luger, MD ^j, Antonella Muraro, MD ^k, Natalija Novak, MD ^b, Thomas A.E. Platts-Mills, MD, PhD ^l, Lanny Rosenwasser, MD ^d, Annika Scheynius, MD, PhD ^m, F. Estelle R. Simons, MD, FRCPC ⁿ, Jonathan Spergel, MD, PhD ^o, Kristiina Turjanmaa, MD, PhD ^p, Ulrich Wahn, MD, PhD ^q,^{^{The EAACI/AAAAI/PRACTALL Consensus Group was chaired by Professor Ulrich Wahn.}}^⁎ , Stefan Weidinger, MD ^r, Thomas Werfel, MD ^s, Torsten Zuberbier, MD ^q
for the European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group^{^†}
The PRACTALL program is a common initiative of both academies, focusing on practical issues of allergology. It is supported by an unrestricted educational grant from Novartis.
^a From the Swiss Institute of Allergy and Asthma Research, Davos
^b University of Bonn
^c Odense University Hospital
^d National Jewish Medical and Research Center, Denver
^e University of Colorado School of Medicine, Denver
^f University Children’s Hospital Geneva
^g McGill University, Montreal
^h Hannover Medical University
ⁱ Zagreb Hospital Center and School of Medicine University of Zagreb
^j Munster University
^k University of Padua
^l Asthma and Allergic Diseases Center, Charlottesville
^m Karolinska University Hospital Solna, Stockholm
ⁿ University of Manitoba
^o The Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine
^p Tampere University Hospital
^q Charité University of Berlin
^r Technical University Munich
^s Hannover Medical School

Reprint requests: Ulrich Wahn, MD, Charité–Universitätsmedizin Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany.

Davos and Geneva, Switzerland, Bonn, Hannover, Munster, Berlin, and Munich, Germany, Odense, Denmark, Denver, Colo, Montreal, Quebec, and Manitoba, Winnipeg, Canada, Zagreb, Croatia, Padua, Italy, Charlottesville, Va, Stockholm, Sweden, Philadelphia, Pa, and Tampere, Finland

Abstract

There are remarkable differences in the diagnostic and therapeutic management of atopic dermatitis practiced by dermatologists and pediatricians in different countries. Therefore, the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology nominated expert teams who were given the task of finding a consensus to serve as a guideline for clinical practice in Europe as well as in North America. The consensus report is part of the PRACTALL initiative, which is endorsed by both academies.

El texto completo de este artículo está disponible en PDF.

Key words : Atopic dermatitis, children, adults, risk factors, immunopathology, diagnosis, systemic treatment, topical treatment

Abbreviations used : AD, APT, CyA, DC, IDEC, LC, MnSOD, pDC, SPT, TCI, T_Reg

Esquema

This article is being copublished by The Journal of Allergy and Clinical Immunology and Allergy.
Disclosure of potential conflict of interest: T. Bieber has consultant arrangements with Novartis and Schering. C. Bindslev-Jensen serves on the advisory board for Schering-Plough. A. Kapp has received grants/research support from Novartis, Astellas, UCB, ALK, and DPO and served on the speakers’ bureau for Novartis, Astellas, UCB, and ALK. K. Turjanmaa a grant and research support from Ansell. U. Wahn has received grants and lecture honoraria from Novartis, MSD, GSK, UCB-Pharma, ALK, and Stallergenes. T. Zuberbier has served on the speakers’ bureau for Novartis, Schering-Plough, UCB, Schering, MSD, Stallergenes, and Leti. M. Boguniewicz has received grants/research support from Novartis, Astellas, and Sinclair and has received lecture honoraria from Novartis and Astellas. D. Y. M. Leung has received grants/research support from Novartis and has served on the speakers’ bureau for Novartis and Astellas. L. Rosenwasser has consultant arrangements with Novartis and Genentech. J. Spergel has received grants/research support from Novartis and the NIH and served on the speakers’ bureau for GSK and Astellas. The rest of the authors have declared that they have no conflict of interest.

Exportación

Vol 118 - N° 1

P. 152-169 - juillet 2006 Regresar al número

Artículo precedente

Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: Development of tolerance using environmental antigens
Yufa Wang, Christine McCusker

| Artículo siguiente

Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects
Scott H. Sicherer, Donald Y.M. Leung

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

conectar o crear una cuenta

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report - 17/08/11

Abstract

Esquema

Exportación citas

Fichero

Contenido

Mi cuenta

Aide & support

Declaración CNIL